Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

The model helps test drugs for clubfoot fibrosis by mimicking cell environments and shows minoxidil reduces harmful collagen links.

The Hairless gene is crucial for healthy skin and hair growth.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Procyanidin B-2 is safe to use on skin as a hair growth product.

Some people have genetic mutations that make them resistant to vitamin D, leading to rickets even with enough vitamin D intake.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Minoxidil can help regrow hair in people with alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

Rat skin can convert minoxidil into its active form, aiding hair growth.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Minoxidil, when used with a diuretic and β-blocking agent, can safely lower blood pressure in most children with severe hypertension due to kidney disease, with minimal side effects.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Basonuclin may help control ribosomal RNA gene activity in skin cells.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Emodin may help hair grow similarly to minoxidil and could treat baldness.